351 related articles for article (PubMed ID: 31447850)
21. HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy.
Murray JM; Zaunders JJ; McBride KL; Xu Y; Bailey M; Suzuki K; Cooper DA; Emery S; Kelleher AD; Koelsch KK;
J Virol; 2014 Mar; 88(6):3516-26. PubMed ID: 24403590
[TBL] [Abstract][Full Text] [Related]
22. Establishment of a Novel Humanized Mouse Model To Investigate
Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677
[TBL] [Abstract][Full Text] [Related]
23. Selective BCL-X
Ren Y; Huang SH; Macedo AB; Ward AR; Alberto WDC; Klevorn T; Leyre L; Copertino DC; Mota TM; Chan D; Truong R; Rohwetter T; Zumbo P; Dündar F; Betel D; Kovacs C; Benko E; Bosque A; Jones RB
J Virol; 2021 Jul; 95(15):e0242520. PubMed ID: 33980597
[TBL] [Abstract][Full Text] [Related]
24. Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral Reactivation.
Noel N; Peña R; David A; Avettand-Fenoel V; Erkizia I; Jimenez E; Lecuroux C; Rouzioux C; Boufassa F; Pancino G; Venet A; Van Lint C; Martinez-Picado J; Lambotte O; Sáez-Cirión A; Prado JG
J Virol; 2016 Jul; 90(13):6148-6158. PubMed ID: 27122576
[TBL] [Abstract][Full Text] [Related]
25. Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors.
Yang H; Buisson S; Bossi G; Wallace Z; Hancock G; So C; Ashfield R; Vuidepot A; Mahon T; Molloy P; Oates J; Paston SJ; Aleksic M; Hassan NJ; Jakobsen BK; Dorrell L
Mol Ther; 2016 Nov; 24(11):1913-1925. PubMed ID: 27401039
[TBL] [Abstract][Full Text] [Related]
26. Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.
Rong L; Perelson AS
PLoS Comput Biol; 2009 Oct; 5(10):e1000533. PubMed ID: 19834532
[TBL] [Abstract][Full Text] [Related]
27. From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication.
Shan L; Siliciano RF
Bioessays; 2013 Jun; 35(6):544-52. PubMed ID: 23613347
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
[TBL] [Abstract][Full Text] [Related]
29. HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.
Omondi FH; Chandrarathna S; Mujib S; Brumme CJ; Jin SW; Sudderuddin H; Miller RL; Rahimi A; Laeyendecker O; Bonner P; Yue FY; Benko E; Kovacs CM; Brockman MA; Ostrowski M; Brumme ZL
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602611
[TBL] [Abstract][Full Text] [Related]
30. Virtual memory CD8+ T cells restrain the viral reservoir in HIV-1-infected patients with antiretroviral therapy through derepressing KIR-mediated inhibition.
Jin JH; Huang HH; Zhou MJ; Li J; Hu W; Huang L; Xu Z; Tu B; Yang G; Shi M; Jiao YM; Fan X; Song JW; Zhang JY; Zhang C; Wang FS
Cell Mol Immunol; 2020 Dec; 17(12):1257-1265. PubMed ID: 32210395
[TBL] [Abstract][Full Text] [Related]
31. Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells.
Ruiz A; Blanch-Lombarte O; Jimenez-Moyano E; Ouchi D; Mothe B; Peña R; Galvez C; Genescà M; Martinez-Picado J; Goulder P; Barnard R; Howell B; Clotet B; Prado JG
Front Immunol; 2018; 9():3162. PubMed ID: 30723480
[TBL] [Abstract][Full Text] [Related]
32. Finding a cure for HIV: will it ever be achievable?
Lewin SR; Evans VA; Elliott JH; Spire B; Chomont N
J Int AIDS Soc; 2011 Jan; 14():4. PubMed ID: 21255462
[TBL] [Abstract][Full Text] [Related]
33. Stable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 Infection.
Seu L; Sabbaj S; Duverger A; Wagner F; Anderson JC; Davies E; Wolschendorf F; Willey CD; Saag MS; Goepfert P; Kutsch O
J Virol; 2015 Jul; 89(13):6656-72. PubMed ID: 25878110
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 reservoir dynamics in CD4+ T cells.
Bruner KM; Cohn LB
Curr Opin HIV AIDS; 2019 Mar; 14(2):108-114. PubMed ID: 30531293
[TBL] [Abstract][Full Text] [Related]
35. Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients.
Petitjean G; Al Tabaa Y; Tuaillon E; Mettling C; Baillat V; Reynes J; Segondy M; Vendrell JP
Retrovirology; 2007 Aug; 4():60. PubMed ID: 17727722
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of CD8
McBrien JB; Kumar NA; Silvestri G
Eur J Immunol; 2018 Jun; 48(6):898-914. PubMed ID: 29427516
[TBL] [Abstract][Full Text] [Related]
37. A broad drug arsenal to attack a strenuous latent HIV reservoir.
Stoszko M; Ne E; Abner E; Mahmoudi T
Curr Opin Virol; 2019 Oct; 38():37-53. PubMed ID: 31323521
[TBL] [Abstract][Full Text] [Related]
38. Antibody-Mediated CD4 Depletion Induces Homeostatic CD4
Kumar NA; McBrien JB; Carnathan DG; Mavigner M; Mattingly C; White ER; Viviano F; Bosinger SE; Chahroudi A; Silvestri G; Paiardini M; Vanderford TH
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185596
[TBL] [Abstract][Full Text] [Related]
39. Early Emergence and Long-Term Persistence of HIV-Infected T-Cell Clones in Children.
Bale MJ; Katusiime MG; Wells D; Wu X; Spindler J; Halvas EK; Cyktor JC; Wiegand A; Shao W; Cotton MF; Hughes SH; Mellors JW; Coffin JM; Van Zyl GU; Kearney MF
mBio; 2021 Apr; 12(2):. PubMed ID: 33832973
[TBL] [Abstract][Full Text] [Related]
40. Potential Utility of Natural Killer Cells for Eliminating Cells Harboring Reactivated Latent HIV-1 Following the Removal of CD8
Khoury G; Kulpa DA; Parsons MS
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
